期刊文献+

微生物来源抗肿瘤抗生素SIPI-228的菌种选育及发酵工艺优化 被引量:1

Improvement of Fermentation Technology and Strain Breeding for Anti-cancer Antibiotic SIPI-228
原文传递
导出
摘要 化合物SIPI-228是一种具有抗肿瘤、抗真菌活性的环肽类抗生素。以本室保藏的紫色色杆菌Chromobacterium violaceum SIPI-820作为出发菌,通过紫外(UV)以及UV与硫酸二乙酯联合诱变,获得一株高产突变株SIPI-LH7-16,其发酵产物SIPI-228的产量较出发菌株提高了354%。通过优化摇瓶发酵工艺,SIPI-228的产量达到531 mg/L,较初始工艺提高了254%;5 L发酵罐的发酵水平达到810 mg/L。 SIPI-228 is a cyclic peptide antibiotic with anticancer and antifungal activities. In this paper, a Chromobacterium violaceum named as SIPI-820 kept in our lab. was used as the starting strain. By UV mutation and UV combined with diethyl sulfate treatment, a mutant named as SIPI-LHT-16 was selected and its productivity of SIPI-228 was 354% higher than that of the original strain. After improving its fermentation process, the yield of SIPI-228 in the optimal conditions of shake flask reached to 531 mg/L, which was 254% higher than the initial process. The yield of SIPI-228 reached to 810 mg/L in a 5 L fermentor.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2014年第5期417-420,共4页 Chinese Journal of Pharmaceuticals
基金 科技部"十二五"重大仪器专项(2011YQ15004808) 国家"十二五""重大新药创制"科技重大专项(2012ZX09301002-003)
关键词 环肽类抗生素 紫色色杆菌 SIPI-228 菌株选育 cyclic peptide antibiotics Chromobacterium violaceum SIPI-228 strain breeding
  • 相关文献

参考文献4

二级参考文献63

  • 1Bentfrode J & N Banrice.,Agric Biol Chem[J]. 1976,40:1523 - 1530.
  • 2宜春.产气气杆菌10016异淀粉酶的研究[J].微生物学报,1976,16(4):282-290.
  • 3Nervi C,Borello U,Fazi F,et al.Cancer Res.,2001,61(4):1247-1249
  • 4Kwon H J,Kim M S,Kim M J,et al.Int.J.Cancer,2002,97(3):290-296
  • 5Deroanne C F,Bonjean K,Servotte S,et al.Oncogene,2002,21 (3):427-436
  • 6Yoshida M,Ma tsuyama A,Komatsu Y,et al.Current Medicinal Chemistry,2003,10:1241-1253
  • 7Finnin M S,Donigian J R,Cohen A,et al.Nature,1999,401 (6749):188-193
  • 8Park H J Y J,Kim Y K,Han J W,et al.MEDI-120 in Abstracts of Papers.224th National Meeting of the American Chemical Society,Boston.2002
  • 9Marks P A,Miller T,Richon V M.Curr.Opin.Pharmacol.,2003,3(4):344-351
  • 10Meinke P T,Liberator P.Curr.Med.Chem.,2001,8(2):211-235

共引文献32

同被引文献5

  • 1Ito T, Ouchida M, Morimoto Y, et al. Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo [J]. Cancer lett, 2005, 224(2):311 319.
  • 2Ueda H, Nakajima H, Hori Y, et al. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity [J]. JAntibiot (Tokyo), 1994, 47 (3) : 301--310.
  • 3VanderMolen KM, McCulloch W, Pearce C J, et al. Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide) : a natural product recently approved for cutaneous T-cell lymphoma [J]. JAntibiot (Tokyo), 2011, 64 (8) : 525--531.
  • 4Shigematsu N, Ueda H, Takase S, et al. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. II. Structure determination [J]. J Antibiot (Tokyo), 1994, 47(3): 311--314.
  • 5汤仲明.2011年美国FDA批准药物简介[J].国际药学研究杂志,2012,39(1):71-85. 被引量:6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部